Viewing Study NCT00641095


Ignite Creation Date: 2025-12-24 @ 2:10 PM
Ignite Modification Date: 2026-02-25 @ 4:38 PM
Study NCT ID: NCT00641095
Status: COMPLETED
Last Update Posted: 2018-10-31
First Post: 2008-03-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma
Sponsor: University College, London
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None contiguous stage II mantle cell lymphoma View
None noncontiguous stage II mantle cell lymphoma View
None stage I mantle cell lymphoma View
None stage III mantle cell lymphoma View
None stage IV mantle cell lymphoma View